The Nightview Fund's 2024 annual letter explores five transformative trends they are tracking in 2025 and beyond. Click here ...

Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital ...

ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...

Welcome to Duos Technologies' Fourth Quarter and Full Year 2024 Earnings Conference Call. Joining us for today's call are Duos' CEO, Chuck Ferry, and CFO, Adrian Goldfarb. Following their remarks, we ...

With tariff fears, inflationary concerns a potential recession, and strong central bank buying, gold is at record highs above ...

Machine learning methods enable the efficient mining of large amounts of data from corporate reports. In her doctoral ...

Transformational 2024: successfully advanced from preclinical to clinical stage companyStrengthened leadership team to drive growth and advance ...

PyroGenesis recorded revenue of $4.2 million in the fourth quarter of 2024 (“Q4, 2024”), representing an increase of $1.2 million when compared to $3.0 million recorded in the fourth quarter of 2023 ( ...